Can Tikosyn (dofetilide) be co‑administered with digoxin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Tikosyn and Digoxin Be Co-Administered?

Yes, Tikosyn (dofetilide) and digoxin can be given together, but this combination requires heightened vigilance due to an increased risk of Torsade de Pointes, despite no pharmacokinetic interaction between the drugs. 1

Key Evidence from FDA Labeling

The FDA label for Tikosyn explicitly addresses this combination 1:

  • Pharmacokinetic studies in healthy volunteers showed that Tikosyn does not affect digoxin levels - there is no drug-drug interaction affecting absorption, distribution, or elimination
  • However, in clinical patient populations, concomitant digoxin administration was associated with a higher occurrence of Torsade de Pointes
  • Importantly, no increase in mortality was observed in patients taking both medications

The Clinical Nuance

The increased Torsade de Pointes risk appears related to patient factors rather than a true drug interaction:

  • Patients requiring digoxin typically have more severe structural heart disease
  • Structural heart disease is itself an independent risk factor for ventricular arrhythmias
  • The FDA label acknowledges: "It is not clear whether this represents an interaction with TIKOSYN or the presence of more severe structural heart disease in patients on digoxin" 1

Practical Management Algorithm

When combining these medications:

  1. Ensure proper Tikosyn initiation protocol - hospitalization with continuous ECG monitoring for 3 days 1
  2. Monitor QTc interval closely - check baseline and serially during initiation
  3. Maintain electrolyte balance - keep potassium and magnesium in normal range (hypokalemia/hypomagnesemia dramatically increase Torsade risk)
  4. Dose Tikosyn based on creatinine clearance - both drugs are renally eliminated 1
  5. Monitor digoxin levels - aim for lower therapeutic range (0.5-0.9 ng/mL) given contemporary evidence suggesting increased mortality above 1.2 ng/mL 2

Supporting Research Evidence

A dedicated pharmacokinetic study confirmed that 5 days of dofetilide treatment did not significantly affect steady-state digoxin levels, and no digoxin dose adjustment is needed 3. An expert review from 2000 explicitly states that "dofetilide can be co-administered with digoxin and beta-blockers" 4.

Critical Pitfalls to Avoid

  • Do not assume the combination is contraindicated - it is not, unlike verapamil, ketoconazole, trimethoprim, or HCTZ which are absolute contraindications with Tikosyn 1
  • Do not neglect the mandatory hospitalization requirement for Tikosyn initiation regardless of concomitant medications
  • Do not allow electrolyte abnormalities - this is the most modifiable risk factor for Torsade de Pointes
  • Recognize that digoxin is listed among rate control options in contemporary AF guidelines alongside Tikosyn as a rhythm control agent 2, 5

The combination is permissible and commonly used in clinical practice, particularly in patients with atrial fibrillation requiring both rate and rhythm control strategies.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.